(Story updated to add Cramer's comments on growth stocks and how to trade Apple.) NEW YORK ( TheStreet) -- While this week's trading action brought an overblown sell-off, Jim Cramer told his "Mad Money" TV show viewers on Friday that next week brings renewed hope. He said if there's another big sell-off, he's just got the stock to buy. Cramer's game plan for next week included several "look-and-listen" earnings calls, including Clean Energy Fuels ( CLNE) and Urban Outfitters ( URBN) on Monday. He said Clean Energy should provide a read on natural gas adoption for America's truck fleet, while Urban Outfitters needs to detail a plan to reignite growth. Tuesday brings a pair of investor conferences in the oil patch. Cramer said that Anadarko Petroleum ( APC) and Chevron ( CVX) should give investors a handle on the state of the world's oil and gas supply. Then on Wednesday, Cramer said he'll be watching the short squeeze in Vera Bradley ( VRA), a stock he's previously said is far to hot to handle. Next week also brings a Federal Reserve meeting on Tuesday and the February consumer price index and industrial production numbers on Friday, three more "look and listen" data points. So what should investors actually buy next week? Cramer said he's bullish on the IPO of Dreamware, an ecommerce software maker. But his pick of the week was discount retailer Ross Stores ( ROST), a stock Cramer said he'd buy aggressively on any weakness or sell-off in the market.
Safe DividendIn the "Executive Decision" segment, Cramer spoke with Gordon Kerr, president and CEO of Enerplus ( ERF), a Canadian oil and gas producer that sports a hefty 9.1% yield. Kerr said the Enerplus has enjoyed a lot of successes in both the U.S. and Canada over its 25-year history and plans to continue to spend money adding acreage and reserves in both the Bakken and Marcellus shale fields here in the U.S. He said even with rising costs in the Bakken region, each long well that Enerplus drills provides $12 million to $13 million is profits for the company. When asked about the companies financing options and whether Enerplus' dividend is safe, Kerr said that his company has a lot of flexibility, including the possibility to offer long-term debt, partner with others to develop some if its longer-term opportunities or sell an equity stake in some other investments that it has made. In short, Kerr said the dividend is safe and Enerplus will even be expanding its dividend reinvestment plan to include U.S. shareholders soon. Kerr was also a big proponent of using domestic natural gas for surface vehicles. He said while gas prices haven't curbed economic activity yet, the ability to reduce the carbon footprint while using a domestic resource just makes sense. He said there's a great chance than ever that both the U.S. and Canada will be exporting natural gas soon given our huge supplies and inability to use it. Cramer said he's a fan of Enerplus and will be a big proponent of the dividend reinvestment plan as soon as that becomes available for U.S. shareholders.
Analyzing a Speculative StockFor "Speculation Friday," Cramer dove into the stock of Solazyme ( SZYM) and offered viewers a look into the step-by-step process he uses to evaluate a speculative stock. Step one, what does it do? Cramer said that Solazyme is developing an industrial biotech platform that uses algae to turn plants into specialty oils. The company has almost no sales and even fewer profits, but does have a ton of potential applications, including everything from personal care products to bio-fuel for aviation. Step two, bloodlines. Cramer said Solazyme was founded in 2003 but only came public in 2011. It's cofounders include a science guy and a business guy, and its CFO is a finance guy, completing the needed trifecta. The IPO had great underwriters in Morgan Stanley ( MS) and Goldman Sachs ( GS). Step three, potential upside. Solazyme has created a host of valuable partnerships, including with Bungee ( BG), an agricultural giant, Chevron ( CVX), makers of diesel fuel, the U.S. Navy, which needs bio-fuels, and Sephora, makers of skin care and cosmetics. Step four, addressable market. Cramer said the market opportunities for Solazyme are gigantic, if the company can actually ramp up production of its technologies in any one of its many market opportunities. The company's first plant is expected to come online in mid-2013. Step five, the risks. Cramer said the company has enough capital to fund itself, with $243 million in cash, a solid balance sheet and the ability to borrow more if it needs to. What about competition? Solazyme smarter partnered with just about everyone who would potentiallyy want to compete with it. Cramer said once again that the only real risk is if the company can execute on its plans. Step six, your personal risk tolerance. Cramer said with no real catalyst until 2013, the decision to own Solazyme should only be made if investors feel it fits their personal risk tolerances. But by using these six steps, he said investors can easily make a smart decision on this, or any other, speculative stock they come across.